A type I interferon signature in monocytes is associated with poor response to interferon-β in multiple sclerosis
Open Access
- 9 September 2009
- journal article
- research article
- Published by Oxford University Press (OUP) in Brain
- Vol. 132 (12) , 3353-3365
Abstract
The effect of interferon-beta in multiple sclerosis is modest and many patients do not respond to treatment. To date, no single biomarker reliably correlates with responsiveness to interferon-β in multiple sclerosis. In the present study, genome-wide expression profiling was performed in peripheral blood mononuclear cells from 47 multiple sclerosis patients treated with interferon-β for a minimum of 2 years and classified as responders and non-responders based on clinical criteria. A validation cohort of 30 multiple sclerosis patients was included in the study to replicate gene-expression findings. Before treatment, interferon-β responders and non-responders were characterized by differential expression of type I interferon-induced genes with overexpression of the type interferon-induced genes in non-responders. Upon treatment the expression of these genes remained unaltered in non-responders, but was strongly upregulated in responders. Functional experiments showed a selective increase in phosphorylated STAT1 levels and interferon receptor 1 expression in monocytes of non-responders at baseline. When dissecting this type I interferon signature further, interferon-β non-responders were characterized by increased monocyte type I interferon secretion upon innate immune stimuli via toll-like receptor 4, by increased endogenous production of type I interferon, and by an elevated activation status of myeloid dendritic cells. These findings indicate that perturbations of the type I interferon signalling pathway in monocytes are related to lack of response to interferon-β, and type I interferon-regulated genes may be used as response markers in interferon-β treatment.Keywords
This publication has 44 references indexed in Scilit:
- Genome-Wide Pharmacogenomic Analysis of the Response to Interferon Beta Therapy in Multiple SclerosisArchives of Neurology, 2008
- Selective blockade of the inhibitory Fcγ receptor (FcγRIIB) in human dendritic cells and monocytes induces a type I interferon response programJournal of Experimental Medicine, 2007
- CNS myeloid DCs presenting endogenous myelin peptides 'preferentially' polarize CD4+ TH-17 cells in relapsing EAENature Immunology, 2007
- An Interferon Signature in the Peripheral Blood of Dermatomyositis Patients is Associated with Disease ActivityMolecular Medicine, 2007
- Colon cancer prognosis prediction by gene expression profilingOncogene, 2005
- Transcription-Based Prediction of Response to IFNβ Using Supervised Computational MethodsPLOS Biology, 2004
- Global and Distinct Targets of IRF-5 and IRF-7 during Innate Response to Viral InfectionJournal of Biological Chemistry, 2004
- Viral infection and Toll‐like receptor agonists induce a differential expression of type I and λ interferons in human plasmacytoid and monocyte‐derived dendritic cellsEuropean Journal of Immunology, 2004
- Identification of genes differentially regulated by interferon α, β, or γ using oligonucleotide arraysProceedings of the National Academy of Sciences, 1998
- Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cells.Journal of Experimental Medicine, 1993